Tata India Pharma & Healthcare Fund-Regular Plan-Growth - Portfolio Analysis
- Equity
- Pharma & Healthcare
- Status: Open
Portfolio Overview
As of December 31, 2025
Asset Allocation
Equity: 98.69%Others: 1.31%
Market Cap
Large Cap: 19.91%Mid Cap: 40.02%Small Cap: 37.23%Equity: 1.52%
Number of stocks
37
Top 10 Holdings
98.02% of portfolio
Market Cap of Equity
Large Cap
19.9150%
Mid Cap
40.0169%
Small Cap
37.2311%
Equity
1.5219%
Companies Allocation of Equity
Sun Pharmaceuticals Industries Ltd15.77%
Max Healthcare Institute Ltd Ordinary Shares11.75%
Abbott India Ltd10.97%
Divi's Laboratories Ltd10.02%
HealthCare Global Enterprises Ltd9.68%
Apollo Hospitals Enterprise Ltd9.51%
Cipla Ltd8.29%
Rainbow Childrens Medicare Ltd7.54%
Ipca Laboratories Ltd7.45%
J.B. Chemicals & Pharmaceuticals Ltd7.05%
Sector Allocation of Equity
Healthcare95.00%
Basic Materials3.68%
SIP Amount
Monthly SIP Date
Tata India Pharma & Healthcare Fund-Regular Plan-Growth


Is This Mutual Fund Right for You?
+10k investors used our Suitability Test to get better returns
Fund Suitability Test
Let's Get Started.
Frequently Asked Questions
Everything You Need To Know To Get Started With Confidence
In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.